MacroGenics
MGNX
#8687
Rank
A$0.27 B
Marketcap
A$4.34
Share price
1.62%
Change (1 day)
59.93%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.06937. In 2024 the company made an earnings per share (EPS) of A-$1.48 a decrease over its 2023 EPS that were of A-$0.21.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-86.66%
2024A-$1.48613.33%
2023A-$0.21-92.31%
2022A-$2.71-42.14%
2021A-$4.6836.44%
2020A-$3.43-21.84%
2019A-$4.38-24.58%
2018A-$5.81675.93%
2017A-$0.75-68.05%
2016A-$2.34168.25%
2015A-$0.87-55%
2014A-$1.943400%
2013A-$0.05549-108.68%
2012A$0.6424.49%
2011A$0.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.89-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.94-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.88-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.50-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.14-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.80-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.46 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA